Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 60, Issue 2, Pages 208-211Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jcp.2006.038893
Keywords
-
Categories
Ask authors/readers for more resources
In contrast with adults, children infected by severe acute respiratory syndrome-corona virus (SARS-CoV) develop milder clinical symptoms. Because of this, it is speculated that children vaccinated with various childhood vaccines might develop cross immunity against SARS-CoV. Antisera and T cells from mice immunised with various vaccines were used to determine whether they developed cross reactivity against SARS-CoV. The results showed no marked cross reactivity against SARS-CoV, which implies that the reduced symptoms among children infected by SARS-CoV may be caused by other factors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available